BiotechTube
Annaida Technologies

Annaida Technologies

Zug, Switzerland· Est.
annaida.ch
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Annaida Technologies is pioneering microscale Magnetic Resonance Spectroscopy (MRS) to transform metabolic data into actionable insights for personalized medicine. Founded in 2016 and based in Zug, Switzerland, the company has developed a proprietary, patent-protected platform that analyzes living samples at the nanolitre scale without labels or disruption. It operates a dual business model, offering both dedicated medical devices (microMRS-MED) for fertility clinics and research tools/services (microMRS-LAB/TUBE) for life sciences, positioning itself at the intersection of medical devices, AI-driven diagnostics, and research tools.

Fertility

Technology Platform

AI-driven metabolomic platform based on miniaturized, microchip-based Magnetic Resonance Spectroscopy (MRS) for non-invasive, label-free analysis of nanolitre-scale living samples.

Opportunities

The global IVF market offers a large addressable audience for non-invasive embryo selection tools that can improve outcomes.
The platform's flexibility also creates a significant opportunity in the rapidly growing life sciences research market for organoid, single-cell, and microtissue analysis, where non-invasive metabolic monitoring is a major unmet need.

Risk Factors

Key risks include the challenge of driving adoption in conservative fertility clinics, which requires robust clinical validation.
The company also faces technology validation risks for its novel platform and financial risks associated with scaling a capital-intensive hardware and software business as a private company.

Competitive Landscape

In fertility, Annaida competes with traditional morphological assessment and invasive genetic testing (PGT-A). In research, it competes with other metabolomics techniques (e.g., mass spectrometry) which may be more established but often require destructive sample prep, and with conventional NMR which lacks the required sensitivity for nanolitre volumes. Its unique value is non-invasive, live-sample analysis at the microscale.

More companies in AI / Machine Learning →More companies in Switzerland →